Literature DB >> 2254912

Production of TNF-alpha and IL-1 in active Behçet's disease.

K Hamzaoui, M Hamza, K Ayed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2254912

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  20 in total

1.  A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.

Authors:  Heiner Wedemeyer; Jens G Kuipers; Konrad Streetz; Michael Mengel; Ingolf Schedel; Nikolina Kezmic; Peter Meier; Henning Zeidler; Michael P Manns; Siegfried Wagner
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

2.  Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).

Authors:  J Freysdottir; S Lau; F Fortune
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

4.  LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet's disease.

Authors:  Gleb Slobodin; Yazeed Toukan; Itzhak Rosner; Michael Rozenbaum; Nina Boulman; Elsa Pavlotzky; Aharon Kessel; Elias Toubi
Journal:  Clin Rheumatol       Date:  2006-07-29       Impact factor: 2.980

Review 5.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

6.  Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease.

Authors:  A O Aydintuğ; G Tokgöz; K Ozoran; N Düzgün; A Gürler; H Tutkak
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  Gene expression of tumour necrosis factor-alpha (TNF-alpha) and heat-shock protein (HSP) 70 in patients with Behçet's disease.

Authors:  Y Yamakawa; Y Sugita; Y Takahashi; T Yamakawa; S Tanaka; S Nakamura; J Fukushima; S Kawamoto; S Ohno; K Okuda
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet's disease.

Authors:  Aşkin Ateş; Gülay Kinikli; Nurşen Düzgün; Murat Duman
Journal:  Rheumatol Int       Date:  2005-05-05       Impact factor: 2.631

9.  Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial.

Authors:  H Al-Rayes; R Al-Swailem; M Al-Balawi; N Al-Dohayan; S Al-Zaidi; M Tariq
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

10.  Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.

Authors:  Nurşen Düzgün; Ergin Ayaşlioğlu; Hüseyin Tutkak; Olcay T Aydintuğ
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.